AWHL · Aspira Women's Health Inc. · Executive Compensation
$0.21
-0.01 (-4.55%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Given the above conditions, there is substantial doubt about our ability to continue as a going concern within one year after the date these consolidated interim financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$9.28M
Shares
46.63M
Volume · Oct 20
18.86K
Avg daily vol (3M)
13.99K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Nicole Sandford | Former President, President & Chief Executive Officer | $1,242,280 |
| Sandra Milligan | M.D., J.D. Former President, Interim Chief Executive Officer | $358,429 |
| Torsten Hombeck | Former Chief Financial Officer | $275,204 |
| Minh Merchant | Former General Counsel & Secretary | $159,470 |
| John Kallassy | Former Interim Chief Financial Officer | $85,980 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Nicole Sandford | Former President, President & Chief Executive Officer | $1,035,590 |
| Minh Merchant | Former General Counsel & Secretary | $562,501 |
| Ryan Phan | Chief Scientific and Operating Officer | $532,881 |
| Valerie Palmieri | Former Executive Chair of the Board, President and Chief Executive Officer | $386,264 |
| Torsten Hombeck | Former Chief Financial Officer | $365,662 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Valerie Palmieri | Former Executive Chair of the Board, President and Chief Executive Officer | $653,182 |
| Valerie B. Palmieri | Former Executive Chair of the Board, President, and Chief Executive Officer | $653,182 |
| Nicole Sandford | President, Chief Executive Officer | $604,256 |
| Robert Beechey | Former Chief Financial Officer | $478,717 |
| Minh Merchant | General Counsel & Secretary | $459,083 |
| Ryan Phan | Chief Scientific and Operating Officer | $453,564 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Valerie B. Palmieri | Former Executive Chair of the Board, President, and Chief Executive Officer | $2,692,163 |
| Valerie Palmieri | Former Executive Chair of the Board, President and Chief Executive Officer | $2,692,163 |
| Robert Beechey | Former Chief Financial Officer | $1,084,432 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| John Fraser | Interim Chief Executive Officer | Appointed | 2026-06-22 |
| John Strahley | Chief Accounting Officer | Appointed | 2026-04-30 |
| John Strahley | Chief Financial Officer | Appointed | 2026-04-30 |
| Brian Hungerford | Principal Accounting Officer | Appointed | 2025-09-03 |
| Brian Hungerford | Chief Financial Officer | Appointed | 2025-09-03 |
| Jane Pine Wood | director | Appointed | 2025-07-15 |
| Cindy Hundorfean | Director | Appointed | 2025-04-08 |
| Jack Fraser | Director | Appointed | 2025-04-08 |
| Dr. Jeffrey Cohen | Director | Appointed | 2025-04-08 |
| Cynthia Hundorfean | director | Appointed | 2025-04-08 |
| Julie Carrillo | Principal Accounting Officer | Appointed | 2025-04-08 |
| John Fraser | director | Appointed | 2025-04-08 |
| Jeffrey Cohen, M.D. | director | Appointed | 2025-04-08 |
| Michael Buhle | Chief Executive Officer | Appointed | 2025-03-31 |
| James Crawford | VP of Finance | Resigned | 2025-03-25 |
| Celeste Fralick | director | Resigned | 2025-03-19 |
| Ellen Beausang | director | Appointed | 2025-02-10 |
| Dr. Sandra Milligan | President | Resigned | 2025-02-10 |
| James Crawford | Vice President of Finance | Appointed | 2025-01-31 |
| Michael Buhle | Chief Executive Officer | Appointed | 2025-01-31 |
| John Kallassy | Interim Chief Financial Officer | Resigned | 2025-01-07 |
| Sandra Milligan | interim CEO | Appointed | 2024-12-16 |
| John Ragard | director | Appointed | 2024-07-29 |
| Torsten Hombeck | Chief Financial Officer | Terminated | 2024-06-27 |
| Torsten Hombeck | Corporate Secretary | Appointed | 2024-06-07 |
Leadership
- John Fraser CEO, Board Member
- Michael Buhle CEO
- Nicole Sandford CEO, CFO
- Sandra Milligan CEO
- Dr. Veronica G.H. Jordan Chairman
- Jannie Herchuk Chairman
- Valerie B. Palmieri Chairman
- Brian Hungerford CFO, Chief Accounting Officer
- Dr. Torsten Hombeck CFO
- James Crawford CFO
- John Kallassy CFO
- John Strahley CFO, Chief Accounting Officer
- Torsten Hombeck CFO
- Torsten Hombeck, Ph.D. CFO
- Minh Merchant General Counsel
- Julie Carrillo Chief Accounting Officer
- Marlene McLennan Chief Accounting Officer
- Cindy Hundorfean Board Member
- Cynthia Hundorfean Board Member
- Dr. Jeffrey Cohen Board Member
- Dr. Winfred Parnell Board Member
- Ellen Beausang Board Member
- Jack Fraser Board Member
- Jane Pine Wood Board Member
- Jeffrey Cohen Board Member
- Jeffrey Cohen, M.D. Board Member
- John Ragard Board Member
- Lynn O'Connor Vos Board Member
- Lynn O’Connor Vos Board Member
- Sandra Brooks, M.D. Board Member
- Winfred Parnell Board Member